Aims: We analyzed the efficiency of the Leksell Gamma Knife Perfexion (LGK PFX) in the treatment of multiple metastases and benign tumors. We also compared treatment planning conformity between LGK PFX and LGK 4C for benign tumors. Method: Over a 6-week interval, 37 patients (21 with multiple brain metastases and 16 with benign tumors) underwent radiosurgery using LGK PFX at the University of Pittsburgh. We created dose plans for all patients using Leksell Gamma Plan for LGK PFX and LGK 4C. The same doses were prescribed for both LGK PFX and LGK 4C. Results: No significant difference was observed between LGK 4C and LGK PFX for total beam-on time. The median reduction in setup time on the LGK PFX was 53 min per patient (range 19–125 min) for multiple metastases. The median reduction in setup time on the LGK PFX for benign tumors was 16 min per patient (range 5–53 min). There was no significant difference in the dose conformality between LGK 4C and LGK PFX. Conclusions: This study demonstrated that in addition to its enhanced cranial reach, LGK PFX provided a significant improvement in efficiency for patients with multiple brain metastases. For benign tumor radiosurgery LGK PFX provided improvement in efficiency without a significant difference in conformality.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.